Skip to main content
Log in

Einfluss des primären Lymphknotenstatus kolorektaler Karzinome auf die Entwicklung von Lungenmetastasen und thorakalen Lymphknotenmetastasen

Influence of primary lymph node status of colorectal cancer on the development of pulmonary metastases and thoracic lymph node metastases

  • Originalien
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Die Lunge ist das zweithäufigste Metastasierungsorgan bei Patienten mit einem kolorektalen Karzinom (CRC). Die lymphonodale Metastasierung des CRC stellt einen Prognosefaktor für das Überleben dar.

Fragestellung

In der vorliegenden Studie wurde untersucht, welchen Einfluss die lymphonodale Metastasierung des CRC auf die Lungenmetastasierung, insbesondere die thorakale Lymphknotenmetastasierung besitzt.

Material und Methoden

Retrospektive Analyse von 88 Patienten (n = 56 männlich) mit kurativer Resektion von Lungenmetastasen bei CRC. Primärer Endpunkt: Einfluss des Lymphknotenstatus des CRC auf Lungenmetastasen, sekundäre Endpunkte krankheitsfreies Überleben/Gesamtüberleben. Die statistische Auswertung erfolgte mit SPSS.

Ergebnisse

Bei 48 Patienten bestand ein positiver Lymphknotenstatus des CRC, bei 9 Patienten ein N+-Status der Lungenmetastasierung. Der Lymphknotenstatus des CRC beeinflusste signifikant das Auftreten synchroner Metastasen (p = 0,03), das krankheitsfreie Intervall bis zur Ausbildung metachroner Lungenmetastasen (p = 0,012) und das Gesamtüberleben der Patienten mit einem CRC (p = 0,048). Die 5‑JÜR für CRC-Patienten mit Lungenmetastasen betrug nach pulmonaler Metastasektomie 48,7 %. Der thorakale Lymphknotenbefall beeinflusste das Überleben ebenfalls signifikant (p = 0,001).

Schlussfolgerung

Die Suche nach Lungenmetastasen sollte in das Staging und das Follow-up aller Patienten mit CRC einbezogen werden, insbesondere bei einem positiven Lymphknotenstatus des CRC.

Abstract

Background

The lungs are the second most common organ site for metastases in patients with colorectal cancer (CRC). Lymph node metastasis of CRC represents a prognostic factor for survival.

Objective

The present study investigated the influence of CRC lymph node metastasis on lung metastasis, in particular thoracic lymph node metastasis.

Material and methods

A retrospective analysis of 88 patients (n = 56 male) with curative resection of lung metastases of CRC was performed. Primary endpoint: influence of lymph node status of CRC on lung metastases. Secondary endpoints: disease-free survival and overall survival. Statistical evaluation was carried out with SPSS.

Results

In 48 patients a positive lymph node status of CRC and in 9 patients an N+ status of lung metastases were determined. The lymph node status of the CRC significantly affected the incidence of synchronous metastases (p = 0.03), disease-free interval until formation of metachronous lung metastases (p = 0.012) and the overall survival of patients with CRC (p = 0.048). The 5‑year survival rate for CRC patients with lung metastases was 48.7% after pulmonary metastasectomy. Thoracic lymph node involvement also significantly affected survival (p = 0.001).

Conclusion

Screening for pulmonary metastases should be included in the staging and follow-up of all patients with CRC, especially in patients with a positive lymph node status of the CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Davis SD (1991) CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 180:1–12

    Article  CAS  Google Scholar 

  2. Enblad P, Adami HO, Glimelius B et al (1990) The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 65:2091–2100

    Article  CAS  Google Scholar 

  3. Fiorentino F, Hunt I, Teoh K et al (2010) Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med 103:60–66

    Article  Google Scholar 

  4. Green RJ, Metlay JP, Propert K et al (2002) Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 136:261–269

    Article  CAS  Google Scholar 

  5. Grossmann I, Avenarius JK, Mastboom WJ et al (2010) Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure. Ann Surg Oncol 17:2045–2050

    Article  Google Scholar 

  6. Hamaji M, Cassivi SD, Shen KR et al (2012) Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma? Ann Thorac Surg 94:1796–1800

    Article  Google Scholar 

  7. Harris GJ, Senagore AJ, Lavery IC et al (2002) Factors affecting survival after palliative resection of colorectal carcinoma. Colorectal Dis 4:31–35

    Article  Google Scholar 

  8. Hemminki K, Li X, Dong C (2001) Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 10:793–798

    CAS  PubMed  Google Scholar 

  9. Hermanek P Jr., Wiebelt H, Riedl S et al (1994) Long-term results of surgical therapy of colon cancer. Results of the Colorectal Cancer Study Group. Chirurg 65:287–297

    PubMed  Google Scholar 

  10. Hirosawa T, Itabashi M, Ohnuki T et al (2013) Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. Surg Today 43:494–499

    Article  Google Scholar 

  11. Kanemitsu Y, Kato T, Hirai T et al (2004) Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91:112–120

    Article  CAS  Google Scholar 

  12. Kuba H, Sato N, Uchiyama A et al (1999) Mediastinal lymph node metastasis of colon cancer: report of a case. Surg Today 29:375–377

    Article  CAS  Google Scholar 

  13. Liang P, Nakada I, Hong JW et al (2007) Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis. Ann Surg Oncol 14:470–477

    Article  Google Scholar 

  14. Martini N, Mccormack PM (1998) Evolution of the surgical management of pulmonary metastases. Chest Surg Clin N Am 8:13–27

    CAS  PubMed  Google Scholar 

  15. Meimarakis G, Spelsberg F, Angele M et al (2014) Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor. Ann Surg Oncol 21:2563–2572

    Article  CAS  Google Scholar 

  16. Okumura S, Kondo H, Tsuboi M et al (1996) Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 112:867–874

    Article  CAS  Google Scholar 

  17. Park YJ, Park KJ, Park JG et al (1999) Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 23:721–726

    Article  CAS  Google Scholar 

  18. Pfannschmidt J, Dienemann H, Hoffmann H (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84:324–338

    Article  Google Scholar 

  19. Pfannschmidt J, Muley T, Hoffmann H et al (2003) Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 126:732–739

    Article  Google Scholar 

  20. Pietra N, Sarli L, Thenasseril BJ et al (1998) Risk factors of local recurrence of colorectal cancer: a multivariate study. Hepatogastroenterology 45:1573–1578

    CAS  PubMed  Google Scholar 

  21. Radespiel-Troger M, Hohenberger W, Reingruber B (2004) Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification. Cancer 100:958–967

    Article  Google Scholar 

  22. Read TE, Mutch MG, Chang BW et al (2002) Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 195:33–40

    Article  Google Scholar 

  23. Renaud S, Alifano M, Falcoz PE et al (2014) Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer. Interact Cardiovasc Thorac Surg 18:482–487

    Article  Google Scholar 

  24. Riquet M, Foucault C, Cazes A et al (2010) Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg 89:375–380

    Article  Google Scholar 

  25. Saito Y, Omiya H, Kohno K et al (2002) Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124:1007–1013

    Article  Google Scholar 

  26. Secco GB, Fardelli R, Gianquinto D et al (1997) Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma. A multivariate analysis. Hepatogastroenterology 44:1057–1062

    CAS  PubMed  Google Scholar 

  27. Seebacher G, Decker S, Fischer JR et al (2015) Unexpected lymph node disease in resections for pulmonary metastases. Ann Thorac Surg 99:231–236

    Article  Google Scholar 

  28. Shiomi K, Naito M, Sato T et al (2017) Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer. Ann Med Surg (lond) 20:19–25

    Article  Google Scholar 

  29. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. Ca Cancer J Clin 68:7–30

    Article  Google Scholar 

  30. Tan KK, Lopes Gde L Jr., Sim R (2009) How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 13:642–648

    Article  Google Scholar 

  31. Vogelsang H, Haas S, Hierholzer C et al (2004) Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91:1066–1071

    Article  CAS  Google Scholar 

  32. Welter S, Jacobs J, Krbek T et al (2007) Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31:167–172

    Article  Google Scholar 

  33. Yamazaki T, Takii Y, Okamoto H et al (1997) What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 40:935–938

    Article  CAS  Google Scholar 

  34. Zlobec I, Baker K, Minoo P et al (2008) Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 14:143–148

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-S. Hofmann.

Ethics declarations

Interessenkonflikt

H.-S. Hofmann, C. Doblinger, T. Szöke, C. Grosser, T. Potzger, M. Ried und R. Neu geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hofmann, HS., Doblinger, C., Szöke, T. et al. Einfluss des primären Lymphknotenstatus kolorektaler Karzinome auf die Entwicklung von Lungenmetastasen und thorakalen Lymphknotenmetastasen. Chirurg 90, 403–410 (2019). https://doi.org/10.1007/s00104-018-0742-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-018-0742-y

Schlüsselwörter

Keywords

Navigation